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Introduction
The familial Mediterranean fever (FMF, OMIM 249100)
is an autosomal recessive auto-inflammatory disease
primarily occuring in Armenian, Turkish, Jewish and
Arabic populations. The first clinical symptoms of FMF
usually appear in childhood. The chronic relapsing
inflammation of the serous membranes leads to febrile
attacks often associated with abdominal, joint and/or
chest pains. The most common mutations associated
with FMF were identified in exon 10 of MEFV located
on the short arm of chromosome 16p13.3. MEFV con-
sists of 10 exons and encodes for pyrin/marenostrin
involved in the regulation of NLRP3-inflammasome
activity.
Objectives
In Algeria, FMF is clinically well diagnosed but the dis-
ease-causing variations in MEFV remain poorly
explored. This study aimed to explore the most recur-
rent mutations in exon 10 in suspected Algerian FMF
patients.
Patients and methods
This study included 84 unrelated Algerian patients (42
males and 42 females) aged between 2 to 56 years. All
the patients were recruited from Algerian hospitals and
were clinically suspected to have FMF. Genomic DNA
was extracted from peripheral blood samples using a
standard protocol. Three mutations p.M694I, p.M694V
and p.M680I were initially analyzed by PCR-ARMS. In
the 84 patients, resequencing the entire coding region of
exon 10 was performed on the amplified products on an
ABI Genetic Analyzer for confirmation of the identified
mutations and identification of others.
Results
Genetic analysis showed that 33/84 (39.28%) of patients
carried at least one mutation in exon 10. The most
recurrent mutation was p.M694I which accounted for
18.45% of the total alleles (n= 31/168), followed by
p.M680I (8.33%; 14/168), p.M694V (2.38%; 4/168) and
p.A744S (2.38%; 4/168). The allele p.M694I accounted
for 58.49% of the mutant alleles. Among the patients
with mutations, 9 patients were homozygous, of them 7
were p.M694I/p.M694I, 11 were compound heterozy-
gous, of them 9 were p.M694I/p.M680I and 13 were
heterozygous. In the rest of the patients, no mutation
could be identified.
Conclusion
The current study shows clearly the predominance of
the p.M694I mutation among the Algerian FMF patients
which confirms our precedent results. The mutational
profile identified here offers a tool for guiding the mole-
cular diagnosis of FMF in Algeria.
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